TUBERCULOSIS (TB)
Clinical trials for TUBERCULOSIS (TB) explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS (TB) trials appear
Sign up with your email to follow new studies for TUBERCULOSIS (TB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug naderin may help patients fight infections during cancer and TB therapy
Disease control CompletedThis study tested whether adding Naderin (sodium nucleinate) to standard treatment could reduce complications in 75 patients with cancer, tuberculosis, or hepatitis C. The main group received Naderin plus standard therapy, while the control group received standard therapy alone. …
Matched conditions: TUBERCULOSIS (TB)
Phase: PHASE2, PHASE3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Surgery for tough lung infections: new study reveals key insights on drug resistance
Knowledge-focused CompletedThis study looked at 350 patients who had surgery (decortication) to treat severe lung infections called empyema, including cases caused by tuberculosis and drug-resistant bacteria. The goal was to understand the types of germs causing these infections and how they affect recover…
Matched conditions: TUBERCULOSIS (TB)
Sponsor: University of Health Sciences Lahore • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:09 UTC